Letteratura scientifica selezionata sul tema "Anti-HCoV-229E activity"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "Anti-HCoV-229E activity".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "Anti-HCoV-229E activity":
Hakem, Asma, Lowiese Desmarets, Ramla Sahli, Rawen Ben Malek, Charline Camuzet, Nathan François, Gabriel Lefèvre et al. "Luteolin Isolated from Juncus acutus L., a Potential Remedy for Human Coronavirus 229E". Molecules 28, n. 11 (23 maggio 2023): 4263. http://dx.doi.org/10.3390/molecules28114263.
Parang, Keykavous, Naglaa Salem El-Sayed, Assad J. Kazeminy e Rakesh K. Tiwari. "Comparative Antiviral Activity of Remdesivir and Anti-HIV Nucleoside Analogs against Human Coronavirus 229E (HCoV-229E)". Molecules 25, n. 10 (17 maggio 2020): 2343. http://dx.doi.org/10.3390/molecules25102343.
Chang, Fang-Rong, Chiao-Ting Yen, Mohamed EI-Shazly, Wen-Hsun Lin, Ming-Hong Yen, Kuei-Hsiang Lin e Yang-Chang Wu. "Anti-Human Coronavirus (anti-HCoV) Triterpenoids from the Leaves of Euphorbia Neriifolia". Natural Product Communications 7, n. 11 (novembre 2012): 1934578X1200701. http://dx.doi.org/10.1177/1934578x1200701103.
Kwon, Eun-Bin, Buyun Kim, Young Soo Kim e Jang-Gi Choi. "Anastrozole Protects against Human Coronavirus Infection by Ameliorating the Reactive Oxygen Species–Mediated Inflammatory Response". Antioxidants 13, n. 1 (17 gennaio 2024): 116. http://dx.doi.org/10.3390/antiox13010116.
Al Mosawi, AJ. "Remdesivir Research Progress: An Overview of the Emerging Evidence". Journal of Biomedical Research & Environmental Sciences 1, n. 6 (14 ottobre 2020): 216–18. http://dx.doi.org/10.37871/jbres1146.
Buchowicz, Włodzimierz, e Mariola Koszytkowska-Stawińska. "How Much Potential Do Nucleoside Analogs Offer to Combat Human Corona Viruses?" Organics 5, n. 2 (8 maggio 2024): 71–110. http://dx.doi.org/10.3390/org5020006.
Chen, Lili, Chunshan Gui, Xiaomin Luo, Qingang Yang, Stephan Günther, Elke Scandella, Christian Drosten et al. "Cinanserin Is an Inhibitor of the 3C-Like Proteinase of Severe Acute Respiratory Syndrome Coronavirus and Strongly Reduces Virus Replication In Vitro". Journal of Virology 79, n. 11 (1 giugno 2005): 7095–103. http://dx.doi.org/10.1128/jvi.79.11.7095-7103.2005.
Pasquereau, Sébastien, Zeina Nehme, Sandy Haidar Ahmad, Fadoua Daouad, Jeanne Van Assche, Clémentine Wallet, Christian Schwartz, Olivier Rohr, Stéphanie Morot-Bizot e Georges Herbein. "Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro". Viruses 13, n. 2 (23 febbraio 2021): 354. http://dx.doi.org/10.3390/v13020354.
Lan, Qiaoshuai, Chao Wang, Jie Zhou, Lijue Wang, Fanke Jiao, Yanbo Zhang, Yanxing Cai, Lu Lu, Shuai Xia e Shibo Jiang. "25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human Coronaviruses". International Journal of Molecular Sciences 22, n. 21 (1 novembre 2021): 11869. http://dx.doi.org/10.3390/ijms222111869.
Song, Yabin, Yongqiang Deng, Huiqiang Wang, Zhuchun Bei, Hongjing Gu, Hui Zhao, Hong Wang et al. "Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro". Molecules 27, n. 3 (21 gennaio 2022): 712. http://dx.doi.org/10.3390/molecules27030712.
Tesi sul tema "Anti-HCoV-229E activity":
Hakem, Asma. "Les métabolites spécialisés du genre Juncus : approfondissement de leur potentiel antimicrobien et étude de leur biodisponibilité". Electronic Thesis or Diss., Université de Lille (2022-....), 2023. https://pepite-depot.univ-lille.fr/ToutIDP/EDSMRE/2023/2023ULILR040.pdf.
To address the current challenges raised by emerging diseases (COVID-19 pandemic) and antibiotic resistance, the search for new antimicrobials has become urgent. The present study aims to highlight the potential of plant species, selected according to ecological and chemotaxonomic criteria, as a natural source of compounds with a wide structural diversity and promising biological activities. Juncus species collected from 3 localities in France were investigated for their potential antimicrobial effect against coronaviruses and Gram-positive bacterial strains. For this purpose, the approach of bioguided fractionation was adopted through the use of conventional separation techniques (preparative HPLC and CPC). The antiviral study conducted against the coronavirus HCoV-229E highlighted the antiviral potential of luteolin, a flavone that was isolated from the EtOAc sub-extract of J. acutus stems (locality 2). The screening for antibacterial activity led to the selection of the CH2Cl2 sub-extract of J. inflexus rhizomes (locality 3) for the rest of this study as this enriched-phenanthrene derivative sub-extract demonstrated a remarkable activity in particular against S. aureus strains. Additional experiments to deepen the understanding of the antibacterial effect of some of the isolated phenanthrene derivatives were performed focusing on a methicillin-resistant S. aureus strain that was isolated from a diabetic foot infection. Regarding the promising results, the developement of a topical formulation involving juncusol as an active component was initiated. Bioavailibility studies were also performed on this phenanthrene derivative through in vitro absorption and intestinal permeability experiments across Caco2/HT29-MTX co-cultured cells